| Literature DB >> 35562914 |
Milton Rafael Camacho-Pérez1, Carlos Eduardo Covantes-Rosales1, Gladys Alejandra Toledo-Ibarra1, Ulises Mercado-Salgado1, María Dolores Ponce-Regalado2, Karina Janice Guadalupe Díaz-Resendiz1, Manuel Iván Girón-Pérez1.
Abstract
Organophosphorus pesticides (OPs) are widespread insecticides used for pest control in agricultural activities and the control of the vectors of human and animal diseases. However, OPs' neurotoxic mechanism involves cholinergic components, which, beyond being involved in the transmission of neuronal signals, also influence the activity of cytokines and other pro-inflammatory molecules; thus, acute and chronic exposure to OPs may be related to the development of chronic degenerative pathologies and other inflammatory diseases. The present article reviews and discusses the experimental evidence linking inflammatory process with OP-induced cholinergic dysregulation, emphasizing the molecular mechanisms related to the role of cytokines and cellular alterations in humans and other animal models, and possible therapeutic targets to inhibit inflammation.Entities:
Keywords: cholinergic system; inflammation; organophosphorus pesticides
Mesh:
Substances:
Year: 2022 PMID: 35562914 PMCID: PMC9104626 DOI: 10.3390/ijms23094523
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1General metabolic pathway of organophosphate pesticides with the neurotoxic mechanism of action. (a) The parent organophosphorothionates bioactivated to highly toxic oxon forms by cytochrome P450 through the removal of sulfur attached to phosphorus and insertion of the oxygen atom (oxidative desulphuration) using the reactive and electrophilic iron–oxo intermediate, detoxified by dearylation to form dialkyl thiophosphates (inactive metabolites) or further hydrolyzed to dialkyl phosphates (inactive metabolites) by paraoxonase-1 (PON1) and carboxylesterase (CE) in phase I. Furthermore, phase II involves conjugative reactions carried out by glutathione transferases (GSTs); N-acetyltransferases (NATs); UDP-glucuronosyltransferase (UGTs); and sulphotransferases (SULTs), UDP-glucuronyltransferases (UGT), sulphotransferases (SULT), N-acetyltransferases (NAT), glutathione S-transferases (GST); and is excreted out through urine in a nontoxic form. (b) The oxon metabolite phosphorylates the hydroxyl group of the serine present in the active site of the enzyme acetylcholinesterase (AChE) causing ACh accumulation in the nerve synapsis [12].
Effects on cholinergic systems by OP exposure.
| OPs | Dose | Exposure Time | Cholinergic | Tissue/Cell Line | Organism Model | References |
|---|---|---|---|---|---|---|
| Diazinon | LC50-7.830 ppm, ½ LC50-3.915 ppm | 96 h | ↓ AChE activity | Spleen | Nile tilapia | [ |
| Diazinon | 0.97, 1.95 and 3.91 mg/L | 6, 12, and 24 h | ↓ AChE activity ↓ mAChR, nAChR concentration and ↑ ACh levels. | Spleen | Nile tilapia | [ |
| Diazoxon | 1 nm, 1 µM, and 10 µM | 24 h | ↓ (M3, M4, M5) | Spleen | Nile tilapia | [ |
| Paraoxon | 1 mg/kg | 6 and 24 h | ↓ mAChR M2 | Peripheral blood | Guinea Pig | [ |
| Chlorpyrifos | LD50 | 48 h | ↓ ChAT activity | Cerebral cortex | Male Rat | [ |
| Chlorpyrifos | 1 mg/Kg | 1 h and 6 h | ↓ ChAT activity, nAChR α4, and α7 expression | Forebrain | Human apoE-TR mice | [ |
| Monocrotophos | 0.01, 0.10, or 1.00 mg/L | N/A | ↓ ChAT activity | Embryos | Sea urchin | [ |
| OPs | Acute | N/A | ↓ BuChE activity | Peripheral blood | Human | [ |
↑ increase ↓ decrease; ACh: acetylcholine; AChE: acetylcholinesterase; mAChR: muscarinic ACh receptor; nAChR: nicotinic ACh receptor; ChAT: choline acetyltransferase; VAChT: vesicular ACh transporter; BuChE: butyrylcholinesterase.
Figure 2Neuronal cholinergic system. Ch: Choline; A: acetate; ACh: acetylcholine; AChE: acetylcholinesterase; ChAT: choline acetyltransferase; VaCh: ACh vesicles; mAChR: muscarinic ACh receptor; nAChR: nicotinic ACh receptor.
Figure 3Modulation of signal transduction through the cholinergic system by OP exposure. Exposure to OPs induces AChE inhibition and ACh accumulation, leading to AChR overstimulation. (a) The overactivation of nAChRs and mAChRs leads to increased Ca2+ influx, which in turn induces increased ROS in mitochondria. (b) Increased intracellular Ca2+ induces activation of p38-MAPK and ERK signaling promoting an inflammatory stage through NF-KB the activation and increased levels of pro-inflammatory cytokines (TNF-alpha and IL-6). In addition, intracellular Ca2+ signaling evokes the up-regulation of c-fos expression and IL-2-induced signal transduction in T and B cells, triggering inflammatory responses. (c) OPs cause the inhibition of phospholipase C and decreased CREB phosphorylation and cAMP levels. Reduced CREB phosphorylation promotes NF-κB activation and leads to the degradation of IκB, which allows the release of NF-κB and facilitates its nuclear translocation, where it promotes the transcription of genes involved in pro-inflammatory immune responses. (d) The OP metabolite (DEDTP) promotes the phosphorylation of SOCS3 and the dephosphorylation of STAT5 protein, and leads to the activation of p21, resulting in T-cell arrest. (e) DEDTP also induced the phosphorylation of ERK, JNK, and p38, resulting in the assembly of AP1, ELK,1, and NFAT, which are the major transcription factors involved in the IL-2 autocrine pathway.
Reports of the modulation of the inflammatory process mediated by cytokines due to exposure to OPs.
| OPs | Dose | Exposure Time | Effects of | Inflammation | Organism Model | References |
|---|---|---|---|---|---|---|
| Chlorpyrifos, dimethoate | 0–1000 μM | 24 h | IL-10 was significantly downregulated | ↓ DC-specific cell surface markers (i.e., CD83 and CD209). Inhibition of Akt family | DC, differentiated from the monocyte cell line THP-1 | [ |
| Chlorpyrifos | 0, 001, 10 μM | 24 h | ↓ Expression of IL-1β and TNF-α | Biphasic responses of lysosomal enzyme activity. inhibition NO release | Macrophages from mouse peritoneum | [ |
| Malathion | 200 mg/kg b.w./day | 28 days | ↑ Expression of IL-1β, IL-6 and IFN-γ | ↑ Activities of hepatocellular enzymes in plasma, lipid peroxidation index, CD3+/CD4+ and CD3+/CD4+ percent | Adult male Wistar rats | [ |
| chlorpyrifos | 3.375–13.5 mg/kg | 28 days | ↑ Expression of IL-1β and TNF-α | ↑ Activation of NF- | Male | [ |
| Parathion, chlorpyrifos, and diazinon | 1–100 μM | 24 h | ↑ Expression of TNF-α, IL-1β PDGF (platelet-derived growth factor) and TGF-β (transforming growth factor-β). | ↑ NF-κB activation and ↓AChE activity | THP1 cells differentiated into macrophages | [ |
| Chlorpyrifos | 6.75 mg/kg | 8 weeks | ↑ Expression of IL-6, TLR-2, IL-1β, TNF-α, and NLPR3 | ↑ Expression of apoptotic genes ( | Male rats | [ |
| Triphenyl phosphate | 0, 50, or 150 mg/kg | 30 days | ↑ Expression of IL-6 and TNF-α | ↑ Inflammation in the thalamus and hippocampus. MAPK signaling pathways were significantly affected. | Male mice (C57/BL6) | [ |
| Malathion | 27 mg/kg (1/50 of LD50) | 30 days | ↑ Expression of IF-γ, IL1-β, TNF-α, and NFĸB | ↓AChE levels in serum (30%) and liver (25%) compared to the control group. Lipid peroxidation. | Rats | [ |
| Chlorpyrifos | 0.3–300 μM | 24 h | ↑ Expression of IL-1β and NLRP3 | ↑ Oxidative stress production (NO, MDA, and O2∙) | BV-2 | [ |
| Diazinon | 10–100 μM | 24 h | Induce expression of TNF-α and IL-6 | ↑ ROS generation. Induced expressions of COX-2, iNOS, and cell-surface molecules CD40, CD86, and MHC class II. | RAW264.7 cells | [ |
| Parathion, | 100–2000 µmol/L | 24 h | ↑ Expression of IL-6, GM-CSF and MIP-1α | ↓Viability, intracellular GSH and phosphorylation of STAT3. | Rat | [ |
↑ increase ↓ decrease; IL-6: Interleukin 6; IL-2: Interleukin 2; IL-1β: Interleukin 1 beta; TLR-2: Toll-like receptor; TNF- α: Tumor necrosis factor alpha; NLPR3: NLR family pyrin domain containing 3; IFN-γ: Interferon gamma; GM-CSF: Granulocyte-macrophage colony-stimulating factor; MIP-1α: Macrophage inflammatory protein; IL-10: Interleukin 10.
Effect of OPs on the molecular and cellular parameters of fishes leukocytes as a study model.
| OPs | Dose | Exposure Time | Effects | Tissue/Cell Line | Organism Model | References |
|---|---|---|---|---|---|---|
| Diazinon | LC50-7.830 ppm, ½ LC50-3.915 ppm | 96 h | ↓ AChE activity | Spleen | Nile tilapia | [ |
| Diazinon | 0.97, 1.95 and 3.91 mg/L | 6, 12 and 24 h | ↓ AChE activity ↓mAChR, nAChR concentration and ↑ ACh levels. | Spleen | Nile tilapia | [ |
| Diazoxon | 1 nm, 1 µM, and 10 µM | 24 h | ↓ (M3, M4, M5) | Spleen | Nile tilapia | [ |
| Diazinon | 1.96 mg/L | 96 h | ↑ Respiratory burst and IgM concentration | Spleen | Nile tilapia | [ |
| Diazinon | 0.97, 1.95 and 3.91 mg/L | 6 and 24 h | Alterations in Ca2+ flux and pERK 1/2. | Spleen | Nile tilapia | [ |
| Chlorpyrifos | 0.422 and 0.211 mg/L) | 96 h | ↓ Phagocytic | Peripheral blood | Nile tilapia | [ |
| Diazinon | LC50-7.830 ppm | 96 h | ↓ Phagocytic capacity and cellular proliferation. | Spleen | Nile tilapia | [ |
| Diazinon | 0.97, 1.95 and 3.91 mg/L | 6 and 24 h | ↑ Reactive oxygen species | Peripheral blood | Nile tilapia | [ |
| Chlorpyrifos | 0.051 mg/L | 96 h | ↓ IgM levels and | Spleen | Nile tilapia | [ |
| Diazinon | 0.97, 1.95 and 3.91 mg/L | 12 and 24 h | ↑ Protein oxidative damage. | Liver | Nile tilapia | [ |
| Diazinon | 0.97, 1.95 and 3.91 mg/L | 6 and 24 h | ↑ Neutrophil | Spleen | Nile tilapia | [ |
| Diazoxon | 1 h and 2 h | ↓ Ca2+ flux against PMA and ionomycin | Spleen | Nile tilapia | [ | |
| Temephos | 10 mg/L | 7 and 21 days | AChE inhibition | Smooth muscle |
| [ |
| Temephos | 10 mg/L | 7 days | ↓ Phagocytic capacity | Spleen |
| [ |
| Temephos | 10 mg/L | 7, 14, and 21 days | ↑ Leucocytes death | Spleen |
| [ |
↑ increase ↓ decrease; ACh: acetylcholine; AChE: acetylcholinesterase; mAChR: muscarinic acetylcholine receptor; nAChR: nicotinic acetylcholine receptor; ROS: reactive oxygen species; NETs: neutrophil extracellular traps. IgM: immunoglobulin M; ERK: extracellular signal-regulated kinase.